-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Hempacco (NASDAQ:HPCO) Vs. 22nd Century Group (NASDAQ:XXII) Head to Head Review
Hempacco (NASDAQ:HPCO) Vs. 22nd Century Group (NASDAQ:XXII) Head to Head Review
Hempacco (NASDAQ:HPCO – Get Rating) and 22nd Century Group (NASDAQ:XXII – Get Rating) are both small-cap consumer discretionary companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, profitability, analyst recommendations, institutional ownership, dividends, valuation and earnings.
Earnings & Valuation
This table compares Hempacco and 22nd Century Group's gross revenue, earnings per share and valuation.
Get Hempacco alerts:Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Hempacco | N/A | N/A | N/A | N/A | N/A |
22nd Century Group | $30.95 million | 6.54 | -$32.61 million | ($0.26) | -3.63 |
Hempacco has higher earnings, but lower revenue than 22nd Century Group.
Analyst Recommendations
This is a breakdown of recent recommendations for Hempacco and 22nd Century Group, as reported by MarketBeat.Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Hempacco | 0 | 0 | 0 | 0 | N/A |
22nd Century Group | 0 | 0 | 4 | 0 | 3.00 |
22nd Century Group has a consensus target price of $6.13, suggesting a potential upside of 549.66%. Given 22nd Century Group's higher possible upside, analysts plainly believe 22nd Century Group is more favorable than Hempacco.
Profitability
This table compares Hempacco and 22nd Century Group's net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Hempacco | N/A | N/A | N/A |
22nd Century Group | -111.52% | -51.39% | -44.63% |
Institutional & Insider Ownership
19.8% of 22nd Century Group shares are held by institutional investors. 2.4% of 22nd Century Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Summary
22nd Century Group beats Hempacco on 5 of the 8 factors compared between the two stocks.
About Hempacco
(Get Rating)
Hempacco Co., Inc. manufactures and sells smokable hemp and herb products in California. It offers The Real Stuff hemp smokables. The company was formerly known as The Hempacco Co., Inc. and changed its name to Hempacco Co., Inc. in May 2021. The company was incorporated in 2019 and is headquartered in San Diego, California. Hempacco Co., Inc. operates as a subsidiary of Green Globe International, Inc.
About 22nd Century Group
(Get Rating)
22nd Century Group, Inc., an agricultural biotechnology company, focuses on tobacco harm reduction, reduced nicotine tobacco, and enhancing health and wellness through plant science for the life science and consumer products industries. It develops very low nicotine content tobacco and cigarette products under the VLN King and VLN Menthol King names; and SPECTRUM research cigarettes for use in independent clinical studies. The company has collaboration with Keygene N.V. to develop hemp/cannabis plants for exceptional cannabinoid profiles and other superior agronomic traits for medical, therapeutic, and agricultural uses, as well as other applications. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Buffalo, New York.
Receive News & Ratings for Hempacco Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hempacco and related companies with MarketBeat.com's FREE daily email newsletter.
Hempacco (NASDAQ:HPCO – Get Rating) and 22nd Century Group (NASDAQ:XXII – Get Rating) are both small-cap consumer discretionary companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, profitability, analyst recommendations, institutional ownership, dividends, valuation and earnings.
亨普科(纳斯达克:HPCO-GET评级)和22世纪集团(纳斯达克:XXII-GET评级)都是小型非必需消费品公司,但哪只股票更好?我们将根据这两家公司的风险、盈利能力、分析师建议、机构持股、股息、估值和收益的强弱对它们进行比较。
Earnings & Valuation
收益与估值
This table compares Hempacco and 22nd Century Group's gross revenue, earnings per share and valuation.
此表比较了汉普科和22世纪集团的毛收入、每股收益和估值。
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Hempacco | N/A | N/A | N/A | N/A | N/A |
22nd Century Group | $30.95 million | 6.54 | -$32.61 million | ($0.26) | -3.63 |
总收入 | 价格/销售额比 | 净收入 | 每股收益 | 市盈率 | |
汉普科 | 不适用 | 不适用 | 不适用 | 不适用 | 不适用 |
22世纪集团 | 3095万美元 | 6.54 | -3,261万元 | ($0.26) | -3.63 |
Hempacco has higher earnings, but lower revenue than 22nd Century Group.
汉普科的收益高于22世纪集团,但营收低于22世纪集团。
Analyst Recommendations
分析师建议
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Hempacco | 0 | 0 | 0 | 0 | N/A |
22nd Century Group | 0 | 0 | 4 | 0 | 3.00 |
销售评级 | 保持评级 | 购买评级 | 强劲的买入评级 | 评级分数 | |
汉普科 | 0 | 0 | 0 | 0 | 不适用 |
22世纪集团 | 0 | 0 | 4 | 0 | 3.00 |
22nd Century Group has a consensus target price of $6.13, suggesting a potential upside of 549.66%. Given 22nd Century Group's higher possible upside, analysts plainly believe 22nd Century Group is more favorable than Hempacco.
22世纪集团的普遍目标价为6.13美元,暗示潜在上涨549.66%。考虑到22世纪集团更有可能的上行空间,分析师们显然认为22世纪集团比汉普科更有利。
Profitability
盈利能力
This table compares Hempacco and 22nd Century Group's net margins, return on equity and return on assets.
此表比较了汉普科和22世纪集团的净利润率、股本回报率和资产回报率。
Net Margins | Return on Equity | Return on Assets | |
Hempacco | N/A | N/A | N/A |
22nd Century Group | -111.52% | -51.39% | -44.63% |
净利润率 | 股本回报率 | 资产回报率 | |
汉普科 | 不适用 | 不适用 | 不适用 |
22世纪集团 | -111.52% | -51.39% | -44.63% |
Institutional & Insider Ownership
机构与内部人持股
19.8% of 22nd Century Group shares are held by institutional investors. 2.4% of 22nd Century Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
22世纪集团19.8%的股份由机构投资者持有。22世纪集团2.4%的股份由内部人士持有。强大的机构持股表明,对冲基金、大型基金管理公司和捐赠基金相信,一只股票有望实现长期增长。
Summary
摘要
22nd Century Group beats Hempacco on 5 of the 8 factors compared between the two stocks.
22世纪集团在两只股票比较的8个因素中有5个击败了汉普科。
About Hempacco
关于汉普科
(Get Rating)
(获取评级)
Hempacco Co., Inc. manufactures and sells smokable hemp and herb products in California. It offers The Real Stuff hemp smokables. The company was formerly known as The Hempacco Co., Inc. and changed its name to Hempacco Co., Inc. in May 2021. The company was incorporated in 2019 and is headquartered in San Diego, California. Hempacco Co., Inc. operates as a subsidiary of Green Globe International, Inc.
汉普科公司在加利福尼亚州制造和销售可烟熏大麻和草药产品。它提供真正的大麻烟熏制品。该公司前身为汉普科公司,并于2021年5月更名为汉普科公司。该公司成立于2019年,总部位于加利福尼亚州圣地亚哥。汉普科公司是绿色环球国际公司的子公司。
About 22nd Century Group
关于22世纪集团
(Get Rating)
(获取评级)
22nd Century Group, Inc., an agricultural biotechnology company, focuses on tobacco harm reduction, reduced nicotine tobacco, and enhancing health and wellness through plant science for the life science and consumer products industries. It develops very low nicotine content tobacco and cigarette products under the VLN King and VLN Menthol King names; and SPECTRUM research cigarettes for use in independent clinical studies. The company has collaboration with Keygene N.V. to develop hemp/cannabis plants for exceptional cannabinoid profiles and other superior agronomic traits for medical, therapeutic, and agricultural uses, as well as other applications. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Buffalo, New York.
22世纪集团公司是一家农业生物技术公司,专注于减少烟草危害,减少尼古丁烟草,并通过植物科学为生命科学和消费品行业提高健康和健康。该公司开发尼古丁含量极低的烟草和卷烟产品,并以VLN King和VLN薄荷醇王的名称命名;以及用于独立临床研究的光谱研究香烟。该公司与Keygene N.V.合作开发大麻/大麻植物,用于特殊的大麻素特征和其他用于医疗、治疗和农业以及其他应用的优良农艺性状。22世纪集团成立于1998年,总部设在纽约布法罗。
Receive News & Ratings for Hempacco Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hempacco and related companies with MarketBeat.com's FREE daily email newsletter.
接受《汉普科日报》的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对汉普科和相关公司的最新新闻和分析师评级的每日简要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧